Main Menu
IBI

SEARCH

MEDIA PACK
NEWS
Main Menu

MENU

Current Edition

Upcoming Events

Advertisement

 
 
 
216

United Therapeutics nabs competing PAH drug with $216M SteadyMed buy

Brief: United Therapeutics announced Monday morning that it will acquire competitor SteadyMed for $4.46 per share in cash upfront and another $2.63 per share in …

1 May 2018 216 Drug
Continue Reading →
 
 
 
 
 
 
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Twitter Linkedin
Main Menu
Bio Pharmaceutical Media © 2023, All Rights Reserved – Powered by Teksyte LTD
Tive